Survival Among Patients With HER2-Positive Breast Cancer Treated With Sequential vs Concurrent Chemotherapy

This phase 3 randomized clinical trial compares disease-free and overall survival among patients with operable HER2-positive breast cancer who received concurrent vs sequential administration of neoadjuvant chemotherapy.

https://ift.tt/2M3Jqvi